`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`
`
`
`
`
`
`
`
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`
`
`
`
`
`
`
`
`
`METRICS, INC.
`Petitioner
`
`v.
`
`SENJU PHARMACEUTICAL CO., LTD.
`Patent Owner
`
`
`
`
`
`
`
`
`
`
`
`Case IPR2014-01041
`U.S. Patent No. 8,129,431
`
`
`
`
`
`
`
`
`PATENT OWNER’S UPDATED MANDATORY NOTICES
`PURSUANT TO 37 C.F.R. § 42.8
`
`
`
`
`
`
`
`Pursuant to 37 C.F.R. § 42.8(a)(2), the Patent Owner, Senju Pharmaceutical
`
`Co., Ltd. (“Senju”), hereby submits the following mandatory notices in connection
`
`with this proceeding.
`
`I.
`
`SENJU’S POWER OF ATTORNEY
`
`A Power of Attorney appointing lead and back-up counsel was filed on July
`
`17, 2014 (Paper No. 3) by Patent Owner.
`
`II.
`
`SENJU’S MANDATORY NOTICES
`(a)
`The real party in interest for the Patent Owner is Senju Pharmaceutical Co.,
`
`37 C.F.R. § 42.8(b)(1): Real Party-in-Interest
`
`Ltd. Other real parties-in-interest include Bausch & Lomb, Inc., and Bausch &
`
`Lomb Pharma Holdings Corp.
`
`(b) Related Matters
`1. Judicial
`
`Senju Pharmaceutical Co., Ltd., Bausch & Lomb, Inc., and Bausch & Lomb
`
`Pharma Holdings Corp. v. Lupin, Ltd. and Lupin Pharmaceuticals, Inc., C.A. No.
`
`1:14-CV-00667-JBS-KMW (D.N.J.) ; Senju Pharmaceutical Co., Ltd., Bausch &
`
`Lomb, Inc., and Bausch & Lomb Pharma Holdings Corp. v. Lupin, Ltd. and Lupin
`
`Pharmaceuticals, Inc., C.A. No. 1:14-CV-04149-JBS-KMW (D.N.J.); Senju
`
`Pharmaceutical Co., Ltd., Bausch & Lomb, Inc., and Bausch & Lomb Pharma
`
`Holdings Corp. v. Lupin, Ltd. and Lupin Pharmaceuticals, Inc., C.A. No. 1:14-CV-
`
`05144-JBS-KMW (D.N.J.); Senju Pharmaceutical Co., Ltd., Bausch & Lomb, Inc.,
`
`1
`
`
`
`
`
`and Bausch & Lomb Pharma Holdings Corp. v. Metrics, Inc, Mayne Pharma
`
`Group Limited, Mayne Pharma (USA), Inc., and Coastal Pharmaceuticals, Inc.,
`
`C.A. No. 1:14-cv-03962-JBS-KMW (D.N.J.); Senju Pharmaceutical Co., Ltd.,
`
`Bausch & Lomb, Inc., and Bausch & Lomb Pharma Holdings Corp., v. Metrics,
`
`Inc., Mayne Pharma Group Limited, Mayne Pharma (USA), Inc., and Coastal
`
`Pharmaceuticals, Inc., C.A. No. 1:14-cv-04964-JBS-KMW(D.N.J.), and Senju
`
`Pharmaceutical Co., Ltd., Bausch & Lomb, Inc., and Bausch & Lomb Pharma
`
`Holdings Corp., v. Metrics, Inc., Mayne Pharma Group Limited, Mayne Pharma
`
`(USA), Inc., and Coastal Pharmaceuticals, Inc., C.A. No. 4:14-cv-00141-BO
`
`(E.D.N.C.) which involve the ’431, ’290 patent, and/or ’131 patents.
`
`2. Administrative
`
`Petitioner has filed concurrently with this Petition, a Petition for Inter Partes
`
`review of U.S. Patent No. 8,669,290 (“the ’290 patent”), which issued on March
`
`11, 2014 and claims priority to the application that issued as the ’431 patent. U.S.
`
`Patent No. 8,497,304, a division of the ’431 patent, issued on July 30, 2013 and
`
`claims the priority to the application that issued as the ’431 patent. U.S. Patent No.
`
`8,754,131, a division of the ’290 patent, issued on June 17, 2014 and claims the
`
`priority to the application that issued as the ’431 patent. U.S. Application Serial
`
`Nos. 14/261,720 and 14/269,692 are pending and claim priority to the application
`
`which issued as the ’431 patent.
`
`2
`
`
`
`
`
`
`
`(c)
`
`37 C.F.R. § 42.8(b)(3) and (4): Lead and Back-Up Counsel, and
`Service Information
`
`Senju designates the following counsel to transact all business in the United
`
`States Patent & Trademark Office associated with the above-captioned proceeding.
`
`Lead Counsel
`M. Andrew Holtman (Reg. No. 53,032)
`
`Back-Up Counsel
`Jonathan R. Stroud (Reg. No. 72,518)
`
`Andy.Holtman@finnegan.com
`
`Jonathan.Stroud@finnegan.com
`
`Finnegan, Henderson, Farabow,
`
`Finnegan, Henderson, Farabow,
`
`
`
`Garrett & Dunner, LLP
`
`
`
`Garrett & Dunner, LLP
`
`901 New York Avenue, NW
`
`901 New York Avenue, NW
`
`Washington, DC 20001-4413
`
`Washington, DC 20001-4413
`
`Phone: (202) 408-4131
`
`Phone: (202) 408-4469
`
`Fax: (202) 408-4400
`
`Fax: (202) 408-4400
`
`
`
`Please address all correspondence regarding this proceeding to lead and
`
`back-up counsel. Senju also consents to electronic service by email.
`
`
`
`
`
`3
`
`
`
`
`
`
`
`Dated: September 10, 2014
`
`
`
`
`
`
`
`
`
`
`
`
`
`Respectfully submitted,
`
`
`By: /M. Andrew Holtman/
`M. Andrew Holtman (Reg. No. 53,032)
`Jonathan R. Stroud (Reg. No. 72,518)
`Finnegan, Henderson, Farabow,
`
`Garrett & Dunner, LLP
`901 New York Avenue, NW
`Washington, DC 20001-4413
`Phone: (202) 408-4131
`Fax: (202) 408-4400
`
`
`Attorneys for Patent Owner
`
`4
`
`
`
`
`
`CERTIFICATE OF SERVICE
`
`The undersigned hereby certifies that a copy of the foregoing Patent
`
`Owner’s Mandatory Notices Pursuant to 37 C.F.R. § 42.8 was served on
`
`September 10, 2014, via email directed to counsel of record for the Petitioner at the
`
`Patrick D. McPherson
`PDMcPherson@duanemorris.com
`DUANE MORRIS LLP
`505 9th Street, N.W., Suite 1000
`Washington, DC 20004-2166
`
`Vincent L. Capuano
`VCapuano@duanemorris.com
`100 High Street, Suite 2400
`Boston, MA 02110
`
`
`/Ashley F. Cheung/
`Ashley F. Cheung
`Case Manager
`
`Finnegan, Henderson, Farabow, Garrett &
`Dunner, LLP
`
`
`
`following:
`
`
`
`
`
`